← Evidence map

ArticleFrontiers in oncology2022

POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation.

Zhen ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36119494